Plasma fructosamine to evaluate metabolic control among women with gestational diabetes Utilidad de la medición de fructosamina como indicador de control en pacientes con diabetes gestacional y pregestacional
Author
dc.contributor.author
Raúl Delgado, M.
Author
dc.contributor.author
Victoria Novik, A.
Author
dc.contributor.author
Felipe Cardemil, M.
Author
dc.contributor.author
Diego Santander, A.
Admission date
dc.date.accessioned
2019-03-11T13:03:07Z
Available date
dc.date.available
2019-03-11T13:03:07Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 139, Issue 11, 2018, Pages 1444-1450
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.other
10.4067/S0034-98872011001100008
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165473
Abstract
dc.description.abstract
Background: Metabolic control of diabetic pregnant women is assessed using glycated hemoglobin (HbA1c) levels and fasting blood sugar. Another glycated protein, namely fructosamine, can be an indicator of average glucose levels during the last three weeks. Aim: To evaluate plasma fructosamine as an indicator of glycemic control in women with gestational diabetes. Patients and Methods: Prospective cohort study of 41 pregnant women aged 30 to 37 years, with gestational and pre-gestational diabetes. Blood glucose, HbA1c, fructosamine were measured. Newborn weight, and other prenatal and postnatal variables, were used to evaluate the correlation between metabolic control and the presence or absence of macrosomia. Results: The correlation observed between fructosamine and fasting blood glucose (r = 0.627, p < 0.001) was superior to that of HbA1c and blood glucose (r = 0.516, p < 0.001). No association was observed between macrosomia and levels of fructosamine, nor between the other studied
Plasma fructosamine to evaluate metabolic control among women with gestational diabetes Utilidad de la medición de fructosamina como indicador de control en pacientes con diabetes gestacional y pregestacional